
1. curr atheroscler rep. 2018 feb 8;20(2):9. doi: 10.1007/s11883-018-0708-z.

human immunodeficiency virus infection, antiretroviral therapy, statin: a
clinical update.

zanetti hr(1)(2), roever l(3), gonçalves a(4)(3)(5)(6), resende es(3).

author information: 
(1)master institute education president antônio carlos, avenida minas gerais, 
1889 - centro, araguari, mg, 38.440-046, brazil. hugo.zanetti@hotmail.com.
(2)department clinical research, federal university uberlândia, uberlândia,
mg, brazil. hugo.zanetti@hotmail.com.
(3)department clinical research, federal university uberlândia, uberlândia,
mg, brazil.
(4)master institute education president antônio carlos, avenida minas gerais, 
1889 - centro, araguari, mg, 38.440-046, brazil.
(5)paulista university, brasília, df, brazil.
(6)atenas college, paracatu, mg, brazil.

purpose review: clinical update intended focus relationship
between hiv infection use antiretroviral therapy (art) statin.
recent findings: though art significantly changed course hiv infection, it
is related numerous side effects principally lipid profile. this
way, statins became one used lipid-lowering therapies this
population. clinical update, evaluated studies demonstrate the
relationship molecular mechanisms hiv infection art use trigger
dyslipidemia also use statin reduce condition. have
demonstrated use statin used dyslipidemic hiv-infected people
as long drug interaction art. recently, studies using
rosuvastatin shown greater effects compared statins.

doi: 10.1007/s11883-018-0708-z 
pmid: 29423787  [indexed medline]

